Selenoprotein P median and IQR concentrations in serum and CSF according to diagnosis are reported in Table 1, alongside selenoprotein-P-bound selenium levels and neurodegeneration (t-tau, p-tau181) and amyloidosis (Aβ1-42) biomarkers (available only for MCI and AD participants). Here, SELENOP is linked to amyloidosis.